AIPAC - 25th March 2020
1. IND approved and open for FDA interaction in MBC
2. Planning continuing pending further analysis of AIPAC
There is still an opportunity to move to a small bridging trial (24 patients originally planned in US and EU) subject to OS data being good - very good.
LAG-3, page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $502.1M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.3¢ | $570.8K | 1.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 917268 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 45349 | 3 |
View Market Depth
| Last trade - 16.10pm 31/01/2025 (20 minute delay) ? |
| IMM (ASX) Chart |